MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Net increase(decrease) in cash and cash...-$3,068K Prepaid expenses andother assets-$7,889K Accounts receivable-$7,425K Net income (loss)$5,179K Accounts payable$2,674K Stock-based compensation$1,482K Depreciation andamortization$1,126K Non-cash interestexpense related to sale...$505K Loss on sale ofproperty and equipment-$10K Proceeds from maturitiesof investments$10,000K Proceeds from sale ofproperty and equipment$3K Net cash used inoperating activities-$2,054K Net cash (used in)provided by investing...-$676K Net cash used infinancing activities-$338K Canceled cashflow$26,290K Canceled cashflow$10,003K Unbilled receivable fromgovernment contracts$13,654K Purchases of investments$10,231K Shares acquired tosettle employee tax...$338K Accrued and otherliabilities-$11,443K Deferredrevenue-Collaboration Revenue-$2,815K Non-cash revenue relatedto sale of future...$331K Net accretion ofdiscounts on investments$56K Deferredrevenue-Government Contract-$45K Purchases of property andequipment$448K
Cash Flow

Vaxart, Inc. (VXRT)

Vaxart, Inc. (VXRT)

source: myfinsight.com